Konopleva M - Search Results

1

AXL/MERTK inhibitor ONO-7475 potently synergizes with venetoclax and overcomes venetoclax resistance to kill FLT3-ITD acute myeloid leukemia.

Post SM, Ma H, Malaney P, Zhang X, Aitken MJL, Mak PY, Ruvolo VR, Yasuhiro T, Kozaki R, Chan LE, Ostermann LB, Konopleva M, Carter BZ, DiNardo C, Andreeff MD, Khoury JD, Ruvolo PP. Post SM, et al. Among authors: konopleva m. Haematologica. 2022 Jun 1;107(6):1311-1322. doi: 10.3324/haematol.2021.278369. Haematologica. 2022. PMID: 34732043 Free PMC article.

2

Ligation of cell surface CD38 protein with agonistic monoclonal antibody induces a cell growth signal in myeloid leukemia cells.

Konopleva M, Estrov Z, Zhao S, Andreeff M, Mehta K. Konopleva M, et al. J Immunol. 1998 Nov 1;161(9):4702-8. J Immunol. 1998. PMID: 9794400

3

Expression and function of leptin receptor isoforms in myeloid leukemia and myelodysplastic syndromes: proliferative and anti-apoptotic activities.

Konopleva M, Mikhail A, Estrov Z, Zhao S, Harris D, Sanchez-Williams G, Kornblau SM, Dong J, Kliche KO, Jiang S, Snodgrass HR, Estey EH, Andreeff M. Konopleva M, et al. Blood. 1999 Mar 1;93(5):1668-76. Blood. 1999. PMID: 10029596 Free article.

4

Expression of Bcl-2-related genes in normal and AML progenitors: changes induced by chemotherapy and retinoic acid.

Andreeff M, Jiang S, Zhang X, Konopleva M, Estrov Z, Snell VE, Xie Z, Okcu MF, Sanchez-Williams G, Dong J, Estey EH, Champlin RC, Kornblau SM, Reed JC, Zhao S. Andreeff M, et al. Among authors: konopleva m. Leukemia. 1999 Nov;13(11):1881-92. doi: 10.1038/sj.leu.2401573. Leukemia. 1999. PMID: 10557066

5

Liposomal Bcl-2 antisense oligonucleotides enhance proliferation, sensitize acute myeloid leukemia to cytosine-arabinoside, and induce apoptosis independent of other antiapoptotic proteins.

Konopleva M, Tari AM, Estrov Z, Harris D, Xie Z, Zhao S, López-Berestein G, Andreeff M. Konopleva M, et al. Blood. 2000 Jun 15;95(12):3929-38. Blood. 2000. PMID: 10845930 Free article.

6

CD38 in hematopoietic malignancies.

Konopleva M, Rissling I, Andreeff M. Konopleva M, et al. Chem Immunol. 2000;75:189-206. doi: 10.1159/000058769. Chem Immunol. 2000. PMID: 10851785 Review. No abstract available.

7

Apoptosis regulating proteins as targets of therapy for haematological malignancies.

Kornblau SM, Konopleva M, Andreeff M. Kornblau SM, et al. Among authors: konopleva m. Expert Opin Investig Drugs. 1999 Dec;8(12):2027-2057. doi: 10.1517/13543784.8.12.2027. Expert Opin Investig Drugs. 1999. PMID: 11139839

8

Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia.

Milella M, Kornblau SM, Estrov Z, Carter BZ, Lapillonne H, Harris D, Konopleva M, Zhao S, Estey E, Andreeff M. Milella M, et al. Among authors: konopleva m. J Clin Invest. 2001 Sep;108(6):851-9. doi: 10.1172/JCI12807. J Clin Invest. 2001. PMID: 11560954 Free PMC article.

9

Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia.

Konopleva M, Tsao T, Ruvolo P, Stiouf I, Estrov Z, Leysath CE, Zhao S, Harris D, Chang S, Jackson CE, Munsell M, Suh N, Gribble G, Honda T, May WS, Sporn MB, Andreeff M. Konopleva M, et al. Blood. 2002 Jan 1;99(1):326-35. doi: 10.1182/blood.v99.1.326. Blood. 2002. PMID: 11756188 Free article.

10

Synergistic induction of apoptosis by simultaneous disruption of the Bcl-2 and MEK/MAPK pathways in acute myelogenous leukemia.

Milella M, Estrov Z, Kornblau SM, Carter BZ, Konopleva M, Tari A, Schober WD, Harris D, Leysath CE, Lopez-Berestein G, Huang Z, Andreeff M. Milella M, et al. Among authors: konopleva m. Blood. 2002 May 1;99(9):3461-4. doi: 10.1182/blood.v99.9.3461. Blood. 2002. PMID: 11964319 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

700 results

Search Page